Esophagogastroduodenoscopy

New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms

Retrieved on: 
Monday, May 24, 2021
Medical specialties, Clinical medicine, Medicine, Gastritis, Duodenitis, Esophagogastroduodenoscopy, Immune system disorders, Gastrointestinal tract disorders, Eosinophilic gastroenteritis

The results suggest that eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) may be an underrecognized cause of chronic unexplained GI symptoms in these patients, and that EG/EoD is highly underdiagnosed.

Key Points: 
  • The results suggest that eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) may be an underrecognized cause of chronic unexplained GI symptoms in these patients, and that EG/EoD is highly underdiagnosed.
  • These data suggest that EG/EoD may be associated with these unexplained chronic GI symptoms in these patients and that targeted EG/EoD therapies could provide a benefit.
  • In practice, gastroenterologists may not always take enough biopsies during upper endoscopy (EGD), especially in the absence of obvious mucosal abnormalities.
  • Published literature reports the prevalence of eosinophilic gastritis and/or eosinophilic duodenitis inthe United Statesto be approximately 50,000 people.

Insights on the Veterinary Endoscopy Global Market to 2026 - Players Include Medtronic, Olympus and Steris Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, April 12, 2021
Veterinary, Health, Medicine, Clinical medicine, Medical specialties, Endoscopy, Diagnostic gastroenterology, Medical equipment, Biopsy, Endoscope, Speculum, Esophagogastroduodenoscopy

The most common flexible endoscopic procedures performed both in specialty and general practices are upper and lower GI endoscopy, for direct examination and biopsy of selected areas of the GI tract.

Key Points: 
  • The most common flexible endoscopic procedures performed both in specialty and general practices are upper and lower GI endoscopy, for direct examination and biopsy of selected areas of the GI tract.
  • Companies such as STERIS have experience in Endo-i Veterinary Endoscope repairs, which is one of the significant investments for veterinary practices.
  • Also, the growing pet population along with increasing spending on pet care is fueling the market's growth.
  • Hence, owing to the aforementioned factors, the studied market is expected to witness significant growth in North America over the forecast period.\n"

Olympus Launches HANAROSTENT Esophagus Through-the-Scope (TTS) Stent

Retrieved on: 
Wednesday, October 28, 2020
Medical specialties, Medicine, Clinical medicine, Endoscopy, Interventional radiology, Stent, Esophageal stent, Esophageal, Esophagogastroduodenoscopy

Tech and distributed exclusively through Olympus in the U.S.

Key Points: 
  • Tech and distributed exclusively through Olympus in the U.S.
    For more information on the FDA Clearance and launch of HANAROSTENT Esophagus TTS, please contact Olympus customer service at 1-800-848-9024 or contact your local representative.
  • Pre-loaded into the delivery system, the HANAROSTENT Esophagus TTS fits down the working channel of a standard therapeutic gastroscope and is deployed for placement in the esophagus.
  • Unlike over-the-wire esophageal stents, the new 10.5F HANAROSTENT Esophagus TTS allows for accurate and easy esophageal stenting under direct endoscopic visualization.
  • "Through our valued partnership with Olympus, the HANAROSTENT Esophagus TTS is the sixth stent successfully launched in the U.S. market in the past two years," said Jin-Hyung Park, CEO at M.I.

PENTAX Medical Announces Launch Of Innovative J10 Series Endoscopic Ultrasound Gastroscopes In The United States

Retrieved on: 
Tuesday, September 15, 2020
Medicine, Clinical medicine, Medical ultrasonography, Fuyo Group, Pentax, Endoscopic ultrasound, Esophagogastroduodenoscopy, Medical specialties

MONTVALE, N.J., Sept. 15, 2020 /PRNewswire/ --PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, has announced the launch of the new J10 Series Ultrasound Video Gastroscopes.

Key Points: 
  • MONTVALE, N.J., Sept. 15, 2020 /PRNewswire/ --PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, has announced the launch of the new J10 Series Ultrasound Video Gastroscopes.
  • The new PENTAX Medical J10 Series Ultrasound Video Gastroscopes deliver on both clinical and market needs, offering ergonomic design, renowned image quality and enhanced maneuverability as an EUS solution.
  • Three renowned endoscopic ultrasound experts will present difficult EUS cases and discuss the potential benefits and differences of the new J10 Series lineup.
  • PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.

Olympus Adds HANAROSTENT Esophagus Through the Scope Stent to its Expanding EndoTherapy Portfolio

Retrieved on: 
Thursday, July 16, 2020
Medical specialties, Medicine, Clinical medicine, Endoscopy, Interventional radiology, Stent, Esophageal stent, Gastroenterology, Esophageal cancer, Esophageal, Esophagogastroduodenoscopy, Esophagus

The Through the Scope (TTS) esophageal stent, the newest addition to the Olympus self-expanding stent (SEMS) portfolio, helps to achieve luminal patency in a variety of clinical applications and is designed for use in palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors.

Key Points: 
  • The Through the Scope (TTS) esophageal stent, the newest addition to the Olympus self-expanding stent (SEMS) portfolio, helps to achieve luminal patency in a variety of clinical applications and is designed for use in palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors.
  • Pre-loaded into the delivery system, the HANAROSTENT Esophagus TTS fits down a standard therapeutic gastroscope and is deployed for placement in the esophagus.
  • Unlike over-the-wire esophageal stents, the new 10.5F HANAROSTENT Esophagus TTS allows for accurate and easy esophageal stenting under direct endoscopic visualization.
  • For more information on the FDA Clearance and launch of HANAROSTENT Esophagus TTS, please contact Olympus customer service at 1-800-848-9024 or contact your local representative.

Ohio Gastroenterology Group Recovers Clinic Volumes with Digital Front Office and Queuing Solution

Retrieved on: 
Tuesday, July 14, 2020
Medicine, Diagnostic gastroenterology, Clinical medicine, Colonoscopy, Endoscopy, Esophagogastroduodenoscopy, Gastroenterology

Most recently, the clinic was able to increase its patient volumes to 91% of pre-pandemic numbers in just 16 days after re-opening.

Key Points: 
  • Most recently, the clinic was able to increase its patient volumes to 91% of pre-pandemic numbers in just 16 days after re-opening.
  • Both AlertMDSM and Ohio Gastroenterology Group, Inc., will be offering an educational webinar to share their experience in improving patient volumes on July 15, 2020.
  • The company went on to create products like Cassidi SM , an intelligent electronic charge capture solution and MargieSM , an automated communications solution.
  • Started in 1996, Ohio Gastroenterology Group, Inc. is the region's leading provider of advanced GI procedures, including colonoscopy and upper endoscopy.

China Gastrointestinal Endoscopic Device Market 2020-2026 - Chinese Government has Started Purchasing GI Devices from Local Manufacturers, Rather Than Premium, International Companies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 6, 2020
Medical devices, Health, Medicine, Clinical medicine, Medical specialties, Diagnostic gastroenterology, Gastroenterology, Endoscopy, Endoscopic retrograde cholangiopancreatography, Capsule endoscopy, Cholangiopancreatography, Esophagogastroduodenoscopy, Endoclip

The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • Growth of the Chinese gastrointestinal endoscopic device market will likely be limited by the prevalence of government hospitals.
  • On top of that, the government has started purchasing GI devices from local manufacturers, rather than premium, international companies.
  • This report on the Chinese market for gastrointestinal (GI) endoscopic devices includes gastrointestinal endoscopes, capsule endoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, endoscopic tissue sampling devices and hemostasis devices.

Global Endoscope Market Research Report (2014-2024), Market is Predicted to Reach $28.4 Billion by 2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 3, 2020
Medical devices, Health, Medicine, Endoscopy, Clinical medicine, Medical specialties, Endoscope, Laryngoscopy, Esophagogastroduodenoscopy, Arthroscopy

The "Endoscope Market Research Report: By Type, Application, End User, Geographical Outlook - Global Opportunity Analysis and Growth Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endoscope Market Research Report: By Type, Application, End User, Geographical Outlook - Global Opportunity Analysis and Growth Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
  • From valuing $18.9 billion in 2018, the global endoscope market is predicted to reach $28.4 billion by 2024, advancing at a 7.2% CAGR during the forecast period (2019-2024).
  • The major driving factors of the market are the technological advancements, rising geriatric population, and growing burden of chronic diseases.
  • Based on type, the endoscope market is categorized into colposcope, laparoscope, laryngoscope, cystoscope, bronchoscope, colonoscope, arthroscope, and esophagoscope.

Fractyl Announces Revita-2 Data Showing Revita DMR Provides Statistically Significant Improvements in Blood Glucose and Liver Fat in Type 2 Diabetes with and without NAFLD

Retrieved on: 
Friday, November 8, 2019
Diabetes, Pharmaceutical, Health, Clinical trials, Medical specialties, Medicine, Clinical medicine, Eli Lilly and Company, Hepatitis, Non-alcoholic fatty liver disease, Diabetes, RTT, Insulin resistance, Insulin, Esophagogastroduodenoscopy, Type 2 Diabetes and NAFLD/NASH, Fractyl and RevitaⓇ DMR

In both treatment arms, all patients received a two-week post-procedure graduating diet from liquids to semi-solids and solids.

Key Points: 
  • In both treatment arms, all patients received a two-week post-procedure graduating diet from liquids to semi-solids and solids.
  • The data also showed that Revita DMR, a minimally invasive, outpatient procedural therapy that resurfaces the duodenal mucosa, is safe relative to a sham upper endoscopy procedure.
  • This data supports Revita DMR as a non-pharmacological intervention for patients who are managing type 2 diabetes and NAFLD/NASH and shows that Revita DMR can provide significant improvements in blood glucose levels and liver insulin resistance, even for those patients with NAFLD.
  • These data will be critical to helping us continue development of Revita in type 2 diabetes with NAFLD.

United States Stenting and Dilation Devices Market Report 2019 Featuring Boston Scientific, Cook Medical, Merit Endotek, CONMED, Hobbs Medical, & Olympus

Retrieved on: 
Thursday, April 25, 2019
Medicine, Endoscopy, Clinical medicine, Diagnostic gastroenterology, Interventional radiology, Esophagogastroduodenoscopy, Stent, Dilation, Enteroscopy, Esophageal dilatation, Colonoscopy

DUBLIN, April 25, 2019 /PRNewswire/ -- The "Stenting and Dilation Devices Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 25, 2019 /PRNewswire/ -- The "Stenting and Dilation Devices Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
  • In 2018, the largest segment in the stenting and dilation device market was esophageal dilation balloons.
  • The relatively large size of this segment is mainly due to a significantly higher rate of dilation balloon usage within esophagogastroduodenoscopy (EGD) procedures compared to colonoscopy and enteroscopy.
  • Stenting devices are typically used in conjunction with a dilation device, which is used to dilate the interior diameter of the obstructed pathway.